Recuvyra

RSS

Expired

This medicine's authorisation has expired

fentanyl
MedicineVeterinaryExpired

Romanian is available via eTranslation, the European Commission's machine translation service.

Translate to Romanian | Important information about machine translation

  • Application under evaluation
  • CVMP opinion
  • European Commission decision

Overview

The marketing authorisation for Recuvyra has expired following the marketing-authorisation holder’s decision not to apply for a renewal.

български (BG) (568.84 KB - PDF)

Vizualizare

español (ES) (537.02 KB - PDF)

Vizualizare

čeština (CS) (573.8 KB - PDF)

Vizualizare

dansk (DA) (511.6 KB - PDF)

Vizualizare

Deutsch (DE) (515.35 KB - PDF)

Vizualizare

eesti (ET) (539.37 KB - PDF)

Vizualizare

ελληνικά (EL) (586.2 KB - PDF)

Vizualizare

français (FR) (538.28 KB - PDF)

Vizualizare

italiano (IT) (535.2 KB - PDF)

Vizualizare

latviešu (LV) (569.81 KB - PDF)

Vizualizare

lietuvių (LT) (534.12 KB - PDF)

Vizualizare

magyar (HU) (548.34 KB - PDF)

Vizualizare

Malti (MT) (576.33 KB - PDF)

Vizualizare

Nederlands (NL) (513.44 KB - PDF)

Vizualizare

polski (PL) (552.75 KB - PDF)

Vizualizare

português (PT) (535.52 KB - PDF)

Vizualizare

română (RO) (533.59 KB - PDF)

Vizualizare

slovenčina (SK) (570.05 KB - PDF)

Vizualizare

slovenščina (SL) (564.24 KB - PDF)

Vizualizare

suomi (FI) (533.75 KB - PDF)

Vizualizare

svenska (SV) (535.74 KB - PDF)

Vizualizare

Product information

български (BG) (1.46 MB - PDF)

Vizualizare

español (ES) (876.92 KB - PDF)

Vizualizare

čeština (CS) (1.18 MB - PDF)

Vizualizare

dansk (DA) (873.6 KB - PDF)

Vizualizare

Deutsch (DE) (889.37 KB - PDF)

Vizualizare

eesti (ET) (830.81 KB - PDF)

Vizualizare

ελληνικά (EL) (1.51 MB - PDF)

Vizualizare

français (FR) (864.23 KB - PDF)

Vizualizare

hrvatski (HR) (875.28 KB - PDF)

Vizualizare

italiano (IT) (859.62 KB - PDF)

Vizualizare

latviešu (LV) (1.25 MB - PDF)

Vizualizare

lietuvių (LT) (810.52 KB - PDF)

Vizualizare

magyar (HU) (1.25 MB - PDF)

Vizualizare

Malti (MT) (1.26 MB - PDF)

Vizualizare

Nederlands (NL) (855.45 KB - PDF)

Vizualizare

polski (PL) (1.23 MB - PDF)

Vizualizare

português (PT) (838.3 KB - PDF)

Vizualizare

română (RO) (1 MB - PDF)

Vizualizare

slovenčina (SK) (1.18 MB - PDF)

Vizualizare

slovenščina (SL) (1.13 MB - PDF)

Vizualizare

suomi (FI) (858.03 KB - PDF)

Vizualizare

svenska (SV) (851.7 KB - PDF)

Vizualizare

Íslenska (IS) (879.42 KB - PDF)

Vizualizare

norsk (NO) (836.37 KB - PDF)

Vizualizare
Latest procedure affecting product information:IB/0009/G
13/10/2016

български (BG) (498.29 KB - PDF)

Vizualizare

español (ES) (458.29 KB - PDF)

Vizualizare

čeština (CS) (487.32 KB - PDF)

Vizualizare

dansk (DA) (460.34 KB - PDF)

Vizualizare

Deutsch (DE) (460.75 KB - PDF)

Vizualizare

eesti (ET) (460.29 KB - PDF)

Vizualizare

ελληνικά (EL) (495.78 KB - PDF)

Vizualizare

français (FR) (460.31 KB - PDF)

Vizualizare

hrvatski (HR) (471.53 KB - PDF)

Vizualizare

italiano (IT) (460.57 KB - PDF)

Vizualizare

latviešu (LV) (491.15 KB - PDF)

Vizualizare

lietuvių (LT) (475.45 KB - PDF)

Vizualizare

magyar (HU) (485.61 KB - PDF)

Vizualizare

Malti (MT) (488.27 KB - PDF)

Vizualizare

Nederlands (NL) (458.26 KB - PDF)

Vizualizare

polski (PL) (485.72 KB - PDF)

Vizualizare

português (PT) (460.24 KB - PDF)

Vizualizare

română (RO) (474.03 KB - PDF)

Vizualizare

slovenčina (SK) (487.71 KB - PDF)

Vizualizare

slovenščina (SL) (477.71 KB - PDF)

Vizualizare

suomi (FI) (458.28 KB - PDF)

Vizualizare

svenska (SV) (460.23 KB - PDF)

Vizualizare

Íslenska (IS) (457.47 KB - PDF)

Vizualizare

norsk (NO) (461.18 KB - PDF)

Vizualizare

Product details

Name of medicine
Recuvyra
Active substance
fentanyl
International non-proprietary name (INN) or common name
fentanyl
Species
Dogs
Anatomical therapeutic chemical veterinary (ATCvet) code
QN02AB03

Pharmacotherapeutic group

Nervous system

Therapeutic indication

For the control of pain associated with orthopaedic and soft tissue surgery in dogs.

Authorisation details

EMA product number
EMEA/V/C/002239
Marketing authorisation holder
Eli Lilly and Company Limited 

Eli Lilly and Company Limited
Lilly House
Priestley Road
Basingstoke
Hampshire RG24 9NL
United Kingdom

Marketing authorisation issued
06/10/2011
Expiry of marketing authorisation
13/10/2016
Revision
4

Assessment history

This page was last updated on

Share this page